OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
Jing Wang, Wei Su, Taotao Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 46
Jing Wang, Wei Su, Taotao Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Synthesis, anticancer evaluation of novel hybrid pyrazole-based chalcones, molecular docking, DNA fragmentation, and gene expression: in vitro studies
Norhan Yasser, Farid M. Sroor, Haidan M. El-Shorbagy, et al.
RSC Advances (2024) Vol. 14, Iss. 30, pp. 21859-21873
Open Access | Times Cited: 13
Norhan Yasser, Farid M. Sroor, Haidan M. El-Shorbagy, et al.
RSC Advances (2024) Vol. 14, Iss. 30, pp. 21859-21873
Open Access | Times Cited: 13
RNA-binding motif protein RBM39 enhances the proliferation of gastric cancer cells by facilitating an oncogenic splicing switch in MRPL33
Chengpiao Lu, Jiabin Li, Dongbao Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 1
Chengpiao Lu, Jiabin Li, Dongbao Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 1
Molecular pathways and targeted therapies in head and neck cancers pathogenesis
Marian Constantin, Mariana Carmen Chifiriuc, Coralia Bleoţu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Marian Constantin, Mariana Carmen Chifiriuc, Coralia Bleoţu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Alternative Splicing at the Crossroad of Inflammatory Bowel Diseases and Colitis-Associated Colon Cancer
Paulo Matos, Peter Jordan
Cancers (2025) Vol. 17, Iss. 2, pp. 219-219
Open Access
Paulo Matos, Peter Jordan
Cancers (2025) Vol. 17, Iss. 2, pp. 219-219
Open Access
Studying the impact of chitosan salicylaldehyde/schiff base/CuFe2O4 in PC3 cells via theoretical studies and inhibition of PI3K/AKT/mTOR signalling
Ghada H. Elsayed, Asmaa M. Fahim
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Ghada H. Elsayed, Asmaa M. Fahim
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours
Arnab Ghosh, Rohan Chaubal, Chitrarpita Das, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Arnab Ghosh, Rohan Chaubal, Chitrarpita Das, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Arcyriaflavin A, a cyclin D1/CDK4 inhibitor, suppresses tumor growth, migration, and invasion of metastatic melanoma cells
Dokyeong Kim, Junseong Park, Yoon‐Seob Kim, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Dokyeong Kim, Junseong Park, Yoon‐Seob Kim, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: the critical role of cyclin D
Yasin Ahmadi, Tahran Faiq, Sakhavat Abolhasani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Yasin Ahmadi, Tahran Faiq, Sakhavat Abolhasani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Exploring the role of oral bacteria in oral cancer: a narrative review
Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Parnian Pour Bahrami, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Parnian Pour Bahrami, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Anti-carcinogenic effects of arecaidine but-2-ynyl ester tosylate on breast cancer: proliferation inhibition and activation of apoptosis
Mervenur Yavuz, Buse Nur Kahyaoğulları, Turan Demircan
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Mervenur Yavuz, Buse Nur Kahyaoğulları, Turan Demircan
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
DPHC from Alpinia officinarum Hance specifically modulates the function of CENPU in the cell cycle and apoptosis to ameliorate hepatocellular carcinoma
Zhe Zhu, Xiuxia Lian, Jicheng Hu, et al.
Journal of Ethnopharmacology (2025), pp. 119598-119598
Closed Access
Zhe Zhu, Xiuxia Lian, Jicheng Hu, et al.
Journal of Ethnopharmacology (2025), pp. 119598-119598
Closed Access
Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes
S. P. Singh, Rakesh Bhaskar, Shampa Ghosh, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1082-1082
Open Access
S. P. Singh, Rakesh Bhaskar, Shampa Ghosh, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1082-1082
Open Access
GINS1 facilitates the development of lung adenocarcinoma via Wnt/β-catenin activation
Luyuan Ma, Rongyang Li, Pengyong Li, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Luyuan Ma, Rongyang Li, Pengyong Li, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Inhibition of colorectal cancer cell growth by downregulation of M2-PK and reduction of aerobic glycolysis by clove active ingredients
Lin Liu, Gang Xing, Xiaoyi Guo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Lin Liu, Gang Xing, Xiaoyi Guo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Multi-omics analysis unveils a four-gene prognostic signature in esophageal squamous carcinoma and the therapeutic potential of PKP1
Xiuzhi Zhang, Wang Zhi, Yutong Zhao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Xiuzhi Zhang, Wang Zhi, Yutong Zhao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Single-cell RNA Sequencing in the Study of Human Retinal Organoids
Yi Chen, Hanyue Xu, Lirong Xiao, et al.
Experimental Eye Research (2025) Vol. 256, pp. 110417-110417
Closed Access
Yi Chen, Hanyue Xu, Lirong Xiao, et al.
Experimental Eye Research (2025) Vol. 256, pp. 110417-110417
Closed Access
Clinical efficacy and potential mechanism of ginseng polysaccharides in the treatment of non-small cell lung cancer based on meta-analysis associated with network pharmacology
Qi Zhao, Le Bai, Dongwei Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27152-e27152
Open Access | Times Cited: 2
Qi Zhao, Le Bai, Dongwei Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27152-e27152
Open Access | Times Cited: 2
Association between COVID 19 exposure and expression of malignant pathological features in oral squamous cell carcinoma: A retrospective cohort study
Yufei Hua, Pingchuan Ma, Chunjie Li, et al.
Oral Oncology (2024) Vol. 151, pp. 106740-106740
Closed Access | Times Cited: 2
Yufei Hua, Pingchuan Ma, Chunjie Li, et al.
Oral Oncology (2024) Vol. 151, pp. 106740-106740
Closed Access | Times Cited: 2
mTOR inhibition by AZD2014 alleviates BCR::ABL1 independent imatinib resistance through enhancing autophagy in CML resistant cells
Wei He, Suotian Liu, Wei Wei, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 6, pp. 2770-2789
Open Access | Times Cited: 2
Wei He, Suotian Liu, Wei Wei, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 6, pp. 2770-2789
Open Access | Times Cited: 2
Early Diagnostic Markers for Esophageal Squamous Cell Carcinoma: CNA Gene Identification and cfDNA Detection
Jiamin Chen, Xi Liu, Zhihua Zhang, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 10, pp. 102127-102127
Closed Access | Times Cited: 2
Jiamin Chen, Xi Liu, Zhihua Zhang, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 10, pp. 102127-102127
Closed Access | Times Cited: 2
Identification of Hub of the Hub-Genes From Different Individual Studies for Early Diagnosis, Prognosis, and Therapies of Breast Cancer
Md Shahin Alam, Adiba Sultana, Md. Kaderi Kibria, et al.
Bioinformatics and Biology Insights (2024) Vol. 18
Open Access | Times Cited: 2
Md Shahin Alam, Adiba Sultana, Md. Kaderi Kibria, et al.
Bioinformatics and Biology Insights (2024) Vol. 18
Open Access | Times Cited: 2
Targeted splicing therapy: new strategies for colorectal cancer
Yifeng Zheng, Guoqiang Zhong, Chengcheng He, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Yifeng Zheng, Guoqiang Zhong, Chengcheng He, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined in silico and in vitro approach
MUNEEBA MALIK, MAMOONA MAQBOOL, TOOBA NISAR, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 6, pp. 899-916
Open Access | Times Cited: 4
MUNEEBA MALIK, MAMOONA MAQBOOL, TOOBA NISAR, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 6, pp. 899-916
Open Access | Times Cited: 4
Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix
Xing Zhao, Shen Danhua, Xiaobo Zhang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Xing Zhao, Shen Danhua, Xiaobo Zhang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Proteomic insights into the regulatory function of ARID1A in colon cancer cells
Siripat Aluksanasuwan, Keerakarn Somsuan, Sasithorn Wanna-udom, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access | Times Cited: 1
Siripat Aluksanasuwan, Keerakarn Somsuan, Sasithorn Wanna-udom, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access | Times Cited: 1
